Stay updated on Dociparstat Sodium with Standard Induction in AML Clinical Trial
Sign up to get notified when there's something new on the Dociparstat Sodium with Standard Induction in AML Clinical Trial page.

Latest updates to the Dociparstat Sodium with Standard Induction in AML Clinical Trial page
- Check4 days agoNo Change Detected
- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedAdded a consolidated Locations section listing multiple states (v3.3.3). The previous per-state location blocks were removed (v3.3.2).SummaryDifference2%

- Check27 days agoNo Change Detected
- Check43 days agoChange DetectedPage revision updated from v3.3.1 to v3.3.2; no study details or functionality were changed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check50 days agoChange DetectedRevision updated from v3.2.0 to v3.3.1 with minor UI/functional updates that do not alter the study content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check57 days agoChange DetectedRemoved the site-wide funding/operating status banner from the page; this change does not affect trial details or data. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check72 days agoChange DetectedScreenshots indicate only minor UI/layout adjustments with no changes to core trial details (title, condition, eligibility, arms, or primary outcomes). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check100 days agoChange DetectedCore content updated with new entity (Jazz Pharmaceuticals) and removal of an existing one (Chimerix); version bumped to v3.2.0, and a government funding/operating-status notice added.SummaryDifference3%

Stay in the know with updates to Dociparstat Sodium with Standard Induction in AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dociparstat Sodium with Standard Induction in AML Clinical Trial page.